Acuta Capital Partners, LLC Third Harmonic Bio, Inc. Transaction History

Acuta Capital Partners, LLC

  • $70.3 Million
  • Q4 2024

A detailed history of Acuta Capital Partners, LLC transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 49,800 shares of THRD stock, worth $174,300. This represents 0.73% of its overall portfolio holdings.

Number of Shares
49,800
Previous 15,508 221.12%
Holding current value
$174,300
Previous $210,000 143.81%
% of portfolio
0.73%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$10.29 - $15.4 $352,864 - $528,096
34,292 Added 221.12%
49,800 $512,000
Q3 2024

Nov 14, 2024
BUY
$10.86 - $15.0 $168,416 - $232,620
15,508 New
15,508 $210,000

Others Institutions Holding THRD

# of Institutions
93
Shares Held
40.2M
Call Options Held
100
Put Options Held
0
View Full List

About Third Harmonic Bio, Inc.

THRD Quotes by TradingView
  • Ticker THRD
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,328,900
  • Market Cap $141M
More about THRD
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email